SCHEMBL575284

SCHEMBL575284

CCC(F)COC(=O)OCC(F)CC

nearest known ligand 0.43

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
SOAT1 P35610 1/20 0.35
LMNA P02545 1/20 0.31
HSD17B10 Q99714 1/20 0.31
TDP1 Q9NUW8 2/20 0.31
CYP3A4 P08684 1/20 0.31
TSHR P16473 1/20 0.31
ATM Q13315 1/20 0.31
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23000062 1.00 ALDH1A1 (0.43) ALDH1A1SOAT1LMNAHSD17B10TDP1
SCHEMBL575286 0.83
SCHEMBL575115 0.82 ALDH1A1 (0.33) ALDH1A1
SCHEMBL320430 0.78 ALDH1A1 (0.38) ALDH1A1TDP1
SCHEMBL575131 0.78 ALDH1A1 (0.62) ALDH1A1SOAT1LMNAHSD17B10TSHR
SCHEMBL30747201 0.78 ALDH1A1 (0.62) ALDH1A1SOAT1LMNAHSD17B10TSHR
SCHEMBL4345145 0.77 ALDH1A1 (0.33) ALDH1A1
SCHEMBL1525699 0.77 ALDH1A1 (0.46) ALDH1A1SOAT1LMNAHSD17B10TSHR
SCHEMBL610460 0.76 ALDH1A1 (0.40) ALDH1A1SOAT1CA1CA2
SCHEMBL9936962 0.76 CYP3A4 (0.33) ALDH1A1LMNATDP1CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 278 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023106821-A2 SOLID-STATE ELECTROLYTE FOR SECONDARY BATTERY, AND SECONDARY BATTERY COMPRISING SAME 김병주 2023-06-15 WO claimed
US-10374259-B2 Hydrofluoroether compound, nonaqueous electrolyte solution and lithium ion secondary battery NEC CORPORATION (JP) 2019-08-06 US claimed
US-20180115020-A1 HYDROFLUOROETHER COMPOUND, NONAQUEOUS ELECTROLYTE SOLUTION AND LITHIUM ION SECONDARY BATTERY NEC CORPORATION (JP) 2018-04-26 US claimed
EP-2316822-B1 PREPARATION OF CARBAMATES WITH SOLID CATALYSTS CONSEJO SUPERIOR INVESTIGACION (ES) 2016-10-26 EP claimed
EP-2407449-B1 ONE-POT PRODUCTION OF CARBAMATES USING SOLID CATALYSTS CONSEJO SUPERIOR INVESTIGACION (ES) 2015-01-07 EP claimed
US-8765993-B2 One-pot production of carbamates using solid catalysts CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) 2014-07-01 US claimed
US-8735621-B2 Preparation of carbamates with solid catalysts CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) 2014-05-27 US claimed
US-20120053359-A1 ONE-POT PRODUCTION OF CARBAMATES USING SOLID CATALYSTS UNIVERSIDAD POLITECNICA DE VALENCIA (ES) 2012-03-01 US claimed
EP-2407449-A1 ONE-POT PRODUCTION OF CARBAMATES USING SOLID CATALYSTS Consejo Superior de Investigaciones Científicas (CSIC) (ES) 2012-01-18 EP claimed
US-20110124902-A1 PREPARATION OF CARBAMATES WITH SOLID CATALYSTS Consejo Superior De Investigaciones Cientificas C/Serrano, 117 (ES) 2011-05-26 US claimed
EP-2316822-A1 PREPARATION OF CARBAMATES WITH SOLID CATALYSTS Consejo Superior De Investigaciones Científicas (ES) 2011-05-04 EP claimed
US-20090082588-A1 Process for producing fluorinated carbamates and isocyanates REPSOL YPF, S.A. (ES) 2009-03-26 US claimed
EP-2036884-A1 Process for producing fluorinated isocyanates and carbamates REPSOL YPF S.A. (ES) 2009-03-18 EP claimed
US-20260112701-A1 NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTIC SOLUTION BATTERY INCLUDING NONAQUEOUS ELECTROLYTIC SOLUTION MU IONIC SOLUTIONS CORPORATION (JP) 2026-04-23 US disclosed
EP-4708437-A1 NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTIC SOLUTION BATTERY INCLUDING NONAQUEOUS ELECTROLYTIC SOLUTION MU Ionic Solutions Corporation (JP) 2026-03-11 EP disclosed
US-12494506-B2 Nonaqueous electrolytic solution and energy device including the same MITSUBISHI CHEMICAL CORPORATION (JP) 2025-12-09 US disclosed
EP-1898485-A1 NONAQUEOUS ELECTROLYTE, AND RECHARGEABLE BATTERY WITH NONAQUEOUS ELECTROLYTE Mitsubishi Chemical Corporation (JP) 2008-03-12 EP disclosed
EP-1890357-A1 NONAQUEOUS ELECTROLYTE SOLUTION, NONAQUEOUS ELECTROLYTE SECONDARY BATTERY AND CARBONATE COMPOUND Mitsubishi Chemical Corporation (JP) 2008-02-20 EP disclosed
US-20070178379-A1 Non-aqueous electrolyte secondary battery and non-aqueous electrolyte SANYO ELECTRIC CO., LTD. (JP) 2007-08-02 US disclosed
EP-1806806-A1 NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY AND NON-AQUEOUS ELECTROLYTE Sanyo Electric Co., Ltd. (JP) 2007-07-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260112701-A1 NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTIC SOLUTION BATTERY INCLUDING NONAQUEOUS ELECTROLYTIC SOLUTION NHERF1, SLC9A2, SCNN1B ALDH1A1 3049/4885SOAT1 362/4885LMNA 3498/4885
US-20120053359-A1 ONE-POT PRODUCTION OF CARBAMATES USING SOLID CATALYSTS CA7, CA2, CA4 ALDH1A1 1941/4885SOAT1 727/4885LMNA 4603/4885
US-20110124902-A1 PREPARATION OF CARBAMATES WITH SOLID CATALYSTS ODC1, RCC1, OTC ALDH1A1 2899/4885SOAT1 1877/4885LMNA 1377/4885
US-20090082588-A1 Process for producing fluorinated carbamates and isocyanates SRM, CA4, PRMT3 ALDH1A1 2517/4885SOAT1 812/4885LMNA 3062/4885
US-10374259-B2 Hydrofluoroether compound, nonaqueous electrolyte solution and lithium ion secondary battery NHERF1, SLC9A1, SLC9A2 ALDH1A1 1281/4885SOAT1 675/4885LMNA 4355/4885
US-20180115020-A1 HYDROFLUOROETHER COMPOUND, NONAQUEOUS ELECTROLYTE SOLUTION AND LITHIUM ION SECONDARY BATTERY NHERF1, SLC9A1, SLC9A2 ALDH1A1 1281/4885SOAT1 675/4885LMNA 4355/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.